How Ricciardi was paid
$1.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Lisa RicciardiPresident and Chief Executive Officer | $651,015 | $396,456 | $393,864 | $18,300 | $1,459,635 |
| Anthony Caggiano, M.D., Ph.D.Chief Medical Officer | $503,010 | $185,260 | $221,324 | $18,300 | $927,894 |
| John DoyleChief Financial Officer | $460,575 | $185,260 | $202,653 | $18,300 | $866,788 |
What changed and why
- $1.5MLisa Ricciardi received a total compensation of $1,459,635 for fiscal 2025, representing a decrease from the prior year total of $1,514,353.
- 110%Corporate and individual goals for executives were achieved at a level of 110% by the Compensation Committee.
- 110%Annual cash incentives for Ms. Ricciardi, Dr. Caggiano, and Mr. Doyle were paid out at 110% of their respective target amounts.
- $18,300The company provided 401(k) matching contributions of $18,300 to each named executive officer.
- Long-term incentives granted in 2025 consisted of restricted stock units and stock options.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.